You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Field Portable Mass Spectrometry for Small Molecule Drugs in Clinical Samples
SBC: SPECTRAL ENERGIES LLC Topic: CBD181006We propose a novel two-dimensional mass spectrometry (2D-MS) technique based on ion trap arrays to identify illicit and designer drugs. This approach will give an unprecedented multiplex advantage for miniature mass spectrometry, allowing novice field technicians to rapidly identify drugs affecting the central nervous system based on both the m/z ratio and fragmentation pattern of an ion. Towards ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Dual Formulation of Atropine/Scopolamine with Enhanced Stability
SBC: CMC PHARMACEUTICALS INC Topic: CBD181005CMC Pharmaceuticals, Inc. (Cleveland, OH) is proposing developing a stable, combination product of two small molecule drug candidates as a counter measure to chemical warfare nerve agents (NA). The combination product is expected to exploit complementary pharmacological profiles for optimal muscarinic receptor blockade and anticholinergic activity within the peripheral and central nervous system. ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Circulating Diagnostic Markers of Infectious Disease
SBC: PATHOVACS INCORPORATED Topic: CBD18A001The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. Therefore, the primary objective of this project is to determine feasibility of one suchtechnical approach called Proteomics-based Expression Library Screening (PELS), for identification of pathogen-d ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001The modern warfighter faces the constant threat of endemic infections, multi-drug resistant bacteria and Biological Warfare Agents. In order to provide accurate front-line treatment that will curtail the overuse of antibiotics, a rapid and robust molecula
STTR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense -
Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
SBC: iXpressGenes, Inc. Topic: CBD152004Environmental DNA from three extreme samples will be isolated, cloned into a fosmid library (5760 clones) for sequencing. The sequencing datawill cover ~ 240 Megabases and will be assembled into contigs long enough (~ 40 Kilobases) to represent potential biosynthetic gene clusters(BGCs). This data will be compared to BGC databases looking for homology to antibiotic targets of DoD interest and with ...
SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense -
Contaminated Material Encapsulation Technology for Transportation
SBC: TDA RESEARCH, INC. Topic: CBD161006The United States Department of Defense (DOD) requires a container for the safe transportation of chemically or biologically contaminated materials, in accordance with DOD, federal and international standards.These materials must be packaged in a manner so that they arrive at their destination in good condition and without presenting a hazard to nearby persons during transport.The packaging requir ...
SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense -
Protective Mask Sizing App
SBC: CFD RESEARCH CORPORATION Topic: CBD161005Typical procedures for respirator masks sizing and protective fit test are time-consuming and user intensive, requiring taking anthropometric measurements of the wearer, sampling the wearers breathing zone and the use of specialized tools and equipment. The proposed software app aims to quickly, accurately and automatically perform respirator mask sizing and predict protective fit using only 2D im ...
SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense -
Contaminated Materiel Transfer Case
SBC: MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORP. Topic: CBD161006An improved Contaminated Materiel Transfer Case (CMTC) is needed for use in repatriating contaminated human remains and other contaminated materials.Existing transfer cases are intended for small loads of materials or equipment, and are not conducive for larger materials and human remains.The CMTC must comply with US standards as well as international standards that govern overflight and facilitat ...
SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense -
Selection of blood-brain barrier penetrating single domain antibodies as medial countermeasures for viral induced encephalitis
SBC: GUILD ASSOCIATES INC Topic: CBD161004Alphaviruses pose significant risks to warfighters where encephalitic virus infection can lead to death. There is no effective treatment for alphavirus induced encephalitis and countermeasures are of high importance. Single domain antibodies (sdAb) are low molecular weight engineered antibody fragments composed of a single heavy-chain variable domain which have proven easier to manipulate and re-e ...
SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense